Diagnostic utility of programmed cell death ligand 1 (clone SP142) immunohistochemistry for malignant lymphoma and lymphoproliferative disorders: A brief review-Reference-Cited by-同舟云学术

Diagnostic utility of programmed cell death ligand 1 (clone SP142) immunohistochemistry for malignant lymphoma and lymphoproliferative disorders: A brief review

Published:2021 Issue:4 Volume:61 Page:182-191
ISSN:1346-4280
Container-title:Journal of Clinical and Experimental Hematopathology
language:en
Short-container-title:J Clin Exp Hematopathol

Author:

Sakakibara Ayako¹,Kohno Kei¹,Ishikawa Eri¹,Suzuki Yuka¹,Tsuyuki Yuta¹,Shimada Satoko¹,Shimada Kazuyuki²,Satou Akira³,Takahara Taishi³,Ohashi Akiko³,Takahashi Emiko³,Kato Seiichi⁴,Nakamura Shigeo¹,Asano Naoko⁵

Affiliation:

1. Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan,

2. Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan,

3. Department of Surgical Pathology, Aichi Medical University Hospital, Nagakute, Japan,

4. Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital,

5. Department of Clinical Laboratory, Nagano Prefectural Suzaka Hospital, Nagano, Japan

Publisher

Japanese Society for Lymphoreticular Tissue Research

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jslrt/61/4/61_21003/_pdf

Reference85 articles.

1. 1 Roemer MGM, Advani RH, Ligon AH et al. PD-L1 and PD-L2 Genetic alterations define classical Hodgkin lymphoma and predict outcome. J Clin Oncol. 2016; 34: 2690-2697.

2. 2 De Goycoechea D, Stalder G, Martins F, Duchosal MA. Immune checkpoint inhibition in classical Hodgkin lymphoma: from early achievements towards new perspectives. J Oncol. 2019; 2019: 9513701.

3. 3 Piris MA, Medeiros LJ, Chang KC. Hodgkin lymphoma: a review of pathological features and recent advances in pathogenesis. Pathology. 2020; 52: 154-165.

4. 4 Ilcus C, Bagacean C, Tempescul A et al. Immune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies. OncoTargets Ther. 2017; 10: 2349-2363.

5. 5 Nicolae A, Pittaluga S, Abdullah S et al. EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment. Blood. 2015; 126: 863-872.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombocytopenia, anasarca, and renal insufficiency as severe and rare complications of Hodgkin lymphoma: a case report;Journal of Medical Case Reports;2023-02-21

2. The Immunology of DLBCL;Cancers;2023-01-29

3. Diagnostic approach for classic Hodgkin lymphoma in small samples with an emphasis on PD-L1 expression and EBV harboring in tumor cells: a brief review from morphology to biology;Journal of Clinical and Experimental Hematopathology;2023

4. EBV-positive mucocutaneous ulcer arising in methotrexate-treated rheumatoid arthritis patients: a clinicopathological study of 12 cases with analysis of PD-L1 expression;Journal of Clinical and Experimental Hematopathology;2023

5. Gray zone lymphoma effectively treated with cyclophosphamide, doxorubicin, vincristine, prednisolone, and rituximab chemotherapy: A case report;World Journal of Clinical Cases;2022-06-16